Does REGORAFENIB Cause Colon cancer? 278 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 278 reports of Colon cancer have been filed in association with REGORAFENIB (Stivarga). This represents 2.9% of all adverse event reports for REGORAFENIB.
278
Reports of Colon cancer with REGORAFENIB
2.9%
of all REGORAFENIB reports
110
Deaths
76
Hospitalizations
How Dangerous Is Colon cancer From REGORAFENIB?
Of the 278 reports, 110 (39.6%) resulted in death, 76 (27.3%) required hospitalization, and 10 (3.6%) were considered life-threatening.
Is Colon cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 278 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Colon cancer?
RANITIDINE (1,938)
ADALIMUMAB (452)
FRUQUINTINIB (277)
ETANERCEPT (268)
LENALIDOMIDE (258)
APIXABAN (241)
INFLIXIMAB (241)
PANITUMUMAB (235)
METHOTREXATE (207)
TOFACITINIB (159)
Which REGORAFENIB Alternatives Have Lower Colon cancer Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR